Vaccination strategies for people living with inborn errors of metabolism in Brazil

Jornal de Pediatria - Tập 99 - Trang S70-S80 - 2023
Barbara C.F. Ramos1, Carolina S. Aranda2, Rita S.B. Cardona1, Ana Maria Martins3, Dirceu Solé2, Sue Ann C. Clemens4,5, Ralf Clemens6
1University of Siena, Siena, Italy
2Universidade Federal de São Paulo, Departamento de Pediatria, Disciplina de Alergia, Imunologia Clínica e Reumatologia, São Paulo, SP, Brazil
3Universidade Federal de São Paulo, Departamento de Pediatria, Erros Inatos do Metabolismo e Instituto de Genética, São Paulo, SP, Brazil
4University of Oxford, Pediatric Infectious Disease and Vaccinology, Oxford, United Kingdom
5University of Siena, Institute for Global Health, Siena, Italy
6International Vaccine Institute, Seoul, Republic of Korea

Tài liệu tham khảo

Waters, 2018, Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence, J Glob Health, 8, 1, 10.7189/jogh.08.021102 Saudubray, 2018, Inborn errors of metabolism overview: pathophysiology, manifestations, evaluation, and management, Pediatr Clin N Am, 65, 179, 10.1016/j.pcl.2017.11.002 Ferreira, 2019, A proposed nosology of inborn errors of metabolism, Genet Med, 21, 102, 10.1038/s41436-018-0022-8 Saudubray, 2019, Proposal for a simplified classification of IMD based on a pathophysiological approach: a practical guide for clinicians, J Inherit Metab Dis, 42, 706, 10.1002/jimd.12086 Debray, 2020, Actualités thérapeutiques dans les erreurs innées du métabolisme, Rev Med Liege, 75, 420 Sheck Breilyn, 2020, Established and emerging treatments for patients with inborn errors of metabolism education gaps, Neoreviews, 21, e699, 10.1542/neo.21-10-e699 Najjarbashi, 2015, Ghadimi F. a study on the humoral and complement immune system of patients with organic acidemia, Iran J Allergy Asthma Immunol, 14, 638 Kim, 2017, Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration, Biochem Biophys Res Commun, 482, 569, 10.1016/j.bbrc.2016.11.075 Visser, 2000, Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European study on glycogen storage disease type I, J Pediatr, 137, 187, 10.1067/mpd.2000.105232 Dale, 2019, Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor, Curr Opin Hematol, 26, 16, 10.1097/MOH.0000000000000474 Braudeau, 2013, Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease, Blood Cells Mol Dis, 50, 281, 10.1016/j.bcmd.2013.01.001 Limgala, 2018, Goker-Alpan O. Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher Disease, Blood Cells Mol Dis, 68, 81, 10.1016/j.bcmd.2016.10.015 Limgala, 2016, Time of initiating enzyme replacement therapy affects immune abnormalities and disease severity in patients with gaucher disease, PLoS ONE, 11, 1, 10.1371/journal.pone.0168135 2019 Sociedade Brasileira de Imunizações. Calendario Especiais SBI; 2021. Cerutti, 2015, Vaccination coverage of patients with inborn errors of metabolism and the attitudes of their parents towards vaccines, Vaccine, 33, 6520, 10.1016/j.vaccine.2015.10.073 Hady-Cohen, 2021, Safety and recommendations for vaccinations of children with inborn errors of metabolism, Eur J Paediatr Neurol, 35, 93, 10.1016/j.ejpn.2021.10.002 Naur, 2020, Immunisation issues in patient with mucopolysaccharidosis: a case report, Med J Malaysa, 75, 51 Yılmazbaş, 2021, Evaluation of vaccination status among children with inborn errors of metabolism, Med J Bakırkoy, 17, 11 Zlamy, 2022, Immunological memory and affinity maturation after vaccination in patients with propionic acidemia, Front Immunol, 13, 1, 10.3389/fimmu.2022.774503 Klein, 2011, Evaluation of immunization rates and safety among children with inborn errors of metabolism, Pediatrics, 127, e1139, 10.1542/peds.2010-3706 Wilson, 2010, Revisiting the possibility of serious adverse events from the whole cell pertussis vaccine: were metabolically vulnerable children at risk?, Med Hypotheses, 74, 150, 10.1016/j.mehy.2009.07.014 Brady, 2006, Immunization recommendations for children with metabolic disorders: more data would help, Pediatrics, 118, 810, 10.1542/peds.2006-0846 Tan, 2021, Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis, QJM [Internet], 114, 596, 10.1093/qjmed/hcab077 Cheung, 2021, Case study of hypertriglyceridemia from COVID-19 Pfizer-BioNTech vaccination in a patient with familial hypercholesteremia, Eur Rev Med Pharmacol Sci, 25, 5525 Jing, 2021, A niemann-pick C1 disease child with BCG-itis: a case report and analysis, BMC Pediatr, 21, 218, 10.1186/s12887-021-02671-7 Mao, 2021, Ketoacidotic crisis after vaccination in a girl with beta-ketothiolase deficiency: a case report, Transl Pediatr, 10, 459, 10.21037/tp-20-265 Han, 2020, Clinical presentation, molecular analysis and follow-up of patients with mut methylmalonic acidemia in Shandong province, China. Pediatr Neonatology., 61, 148, 10.1016/j.pedneo.2019.07.004 Mahajan, 2018, AEFI surveillance – the learning curve continues, Indian Pediatr, 55, 707, 10.1007/s13312-018-1365-6 Yang, 2006, Acute metabolic crisis induced by vaccination in seven Chinese patients, Pediatr Neurol, 35, 114, 10.1016/j.pediatrneurol.2005.12.004 Alkan, 2002, Glutaric aciduria type I diagnosed after poliovirus immunization: magnetic resonance findings, Pediatr Neurol, 26, 405, 10.1016/S0887-8994(01)00411-8 Menni, 2012, Vaccination in children with inborn errors of metabolism, Vaccine, 30, 7161, 10.1016/j.vaccine.2012.10.012 Zubarioglu, 2022, Safety of COVID -19 vaccines in children with inborn errors of metabolism in terms of developing metabolic decompensation, J Paediatr Child Health Morgan, 2011, Vaccines are not associated with metabolic events in children with urea cycle disorders, Pediatrics, 127, e1147, 10.1542/peds.2010-1628 Esposito, 2013, Preliminary data on immunogenicity, safety and tolerability of trivalent inactivated influenza vaccine in children with inborn errors of metabolism at risk of decompensation, Vaccine, 31, 5149, 10.1016/j.vaccine.2013.08.058 Barshop, 2008, Attitudes regarding vaccination among practitioners of clinical biochemical genetics, Mol Genet Metabol, 95, 1, 10.1016/j.ymgme.2008.08.001 Ismailova, 2022, Mild disease course of SARS-CoV-2 infections and mild side effects of vaccination in Pompe disease: a cohort description, Orphanet J Rare Dis, 17, 102, 10.1186/s13023-022-02268-y Parikh, 2017, Patient care standards for primary mitochondrial disease: a consensus statement from the mitochondrial medicine society, Genet Med, 19, 1, 10.1038/gim.2017.107 Sirrs S. Clinical guidance on COVID-19 vaccines for people with metabolically unstable inborn errors of metabolism background and context. British Columbia, Ministry of Health, Centre for Desease Control; 2022. Varghese, 2011, Should children with inherited metabolic disorders receive varicella vaccination?, Arch Dis Chid, 96, 99, 10.1136/adc.2008.147934 Saborido-Fiaño, 2021, Letter to the editor concerning the article ‘Safety of vaccines administration in hereditary fructose intolerance, Hum Vaccin Immunother, 17, 2593, 10.1080/21645515.2021.1891816 Gallo G., Mel R., Ros E., Filia A. Guida alle controindicazioni alle vaccinazioni [Internet]. [Cited 2022 Nov 25]. Available from: https://snlg.iss.it/wp-content/uploads/2017/10/C_17_pubblicazioni_2759_allegato.pdf GlaxoSmithKline. Rotarix oral suspension product characteristics. [Cited 2022 Nov 25]; Available from: https://ca.gsk.com/media/6256/rotarix_pm_en.pdf Merck Sharp & Dohme B.V. RotaTeq summary of product characteristics [Internet]. [Cited 2022 Nov 25]. Available from: https://www.ema.europa.eu/en/documents/product-information/rotateq-epar-product-information_en.pdf GlaxoSmithKline Biologicals SA. Rotarix powder product characteristics [Internet]. [Cited 2022 Nov 25]. Available from: https://www.ema.europa.eu/en/documents/product-information/rotarix-epar-product-information_en.pdf Maiorana, 2020, Safety of vaccines administration in hereditary fructose intolerance, Orphanet J Rare Dis, 15, 274, 10.1186/s13023-020-01552-z Merck Sharp & Dohme B.V. M-M-RvaxPro product characteristics [Internet]. [Cited 2022 Nov 25]. Available from: https://www.ema.europa.eu/en/documents/product-information/m-m-rvaxpro-epar-product-information_en.pdf M. Sharp & D. B.V. ProQuad product characteristics [Internet]. [Cited 2022 Nov 25]. Available from: https://www.ema.europa.eu/en/documents/product-information/proquad-epar-product-information_en.pdf Saborido-Fiaño, 2021, Reply letter to “safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance, Hum Vaccin Immunother, 17, 4115, 10.1080/21645515.2021.1959149 Urru, 2021, Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance, Hum Vaccin Immunother, 17, 4112, 10.1080/21645515.2021.1943992 Izquierdo-Garcia, 2022, Reply letter to the editor concerning the article ‘Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance, Hum Vaccin Immunother, 18, 10.1080/21645515.2022.2051414 de Ávila, 2021, Imunizações em pacientes com doenças raras – Posicionamento conjunto da Sociedade Brasileira de Imunizações (SBIm), Associação Brasileira de Alergia e Imunologia (ASBAI) e Sociedade Brasileira de Pediatria (SBP), Arq Asma Alerg Imunol, 5, 36 van Wegberg, 2017, The complete European guidelines on phenylketonuria: diagnosis and treatment, Orphanet J Rare Dis, 12, 162, 10.1186/s13023-017-0685-2 Kingsley, 2006, Immunizations for patients with metabolic disorders, Pediatrics, 118, e460, 10.1542/peds.2005-1257 Sutton, 2012, Chronic management and health supervision of individuals with propionic acidemia, Mol Genet Metabol, 105, 26, 10.1016/j.ymgme.2011.08.034 Kishnani, 2014, Diagnosis and management of glycogen storage disease type I: a practice guideline of the American college of medical genetics and genomics, Genet Med, 16, 1, 10.1038/gim.2014.128 Kishnani, 2010, Glycogen Storage Disease Type III diagnosis and management guidelines, Genet Med, 12, 446, 10.1097/GIM.0b013e3181e655b6 Williams, 2017, Management Strategies for CLN2 disease, Pediatr Neurol, 69, 102, 10.1016/j.pediatrneurol.2017.01.034 World Health Organization (WHO). COVID-19 weekly epidemiological update; 2022. Hamiel, 2021, Experts’ views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease, Br J Haematol, 195, e135, 10.1111/bjh.17693 Oster, 2022, Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021, JAMA, 327, 331, 10.1001/jama.2021.24110 Buoninfante, 2022, Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination, NPJ Vaccines, 7, 141, 10.1038/s41541-022-00569-8 Chang, 2018, Congenital disorders of glycosylation, Ann Transl Med, 6, 477, 10.21037/atm.2018.10.45 Zaffina, 2022, Case report: precision COVID-19 immunization strategy to overcome individual fragility: a case of generalized lipodystrophy type 4, Front Immunol, 13, 1, 10.3389/fimmu.2022.869042 Fois, 2020, Humoral responses to the measles, mumps and rubella vaccine are impaired in Leigh Syndrome French Canadian patients, PLoS ONE, 15, 1, 10.1371/journal.pone.0239860 Kruk, 2019, Vulnerability of pediatric patients with mitochondrial disease to vaccine-preventable diseases, J Allergy Clin Immunol Pract, 7, 2415, 10.1016/j.jaip.2019.03.046 Blank, 2006, Recurrent infections and immunological dysfunction in congenital disorder of glycosylation Ia (CDG Ia), J Inherit Metabolic Dis, 29, 592, 10.1007/s10545-006-0275-2 Lukkarinen, 1999, B and T cell immunity in patients with lysinuric protein intolerance, Clin Exp Immunol, 116, 430, 10.1046/j.1365-2249.1999.00868.x